European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
CancerWorld Issue #110 (December) is Live
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […] |
0 events,
|
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
Virtual Event
The ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time). Register. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|